CIK0001811063 — Shareholder Vote
Panacea Acquisition Corp. · 2023-05-16
To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.
Vote type
other
Outcome
passed
Shares for
153,714,329
Shares against
38,025,124
Data sourced from SEC EDGAR filings. Dates reflect the vote/event date as disclosed in the filing. Outcomes updated when follow-up filings are published.